Martha’s Vineyard TimesScience and Scientists on the Vineyard: Genes at play with CRISPRMartha’s Vineyard TimesCRISPR-Cas9 as a tool for genetic editing has a history that goes back to a 2011 scientific conference at which microbiologist Emmanuelle Cha… Continue reading
Martha’s Vineyard TimesScience and Scientists on the Vineyard: Genes at play with CRISPRMartha’s Vineyard TimesCRISPR-Cas9 as a tool for genetic editing has a history that goes back to a 2011 scientific conference at which microbiologist Emmanuelle Cha… Continue reading
|
‘Advances made in stem cell therapy in Asia far more than those made in US’
The Hindu Indigenously developed therapeutic modules for neuro development disorders like autism have demonstrated a higher rate of recovery and improvement among sufferers, Nandini Gokulchandran, a Mumbai-based researcher in the field of stem cell therapy … |
|
Evolving Education Initiative Keeps Nurses Up-to-Date on CAR T Cell Therapy Best Practices
Oncology Nurse Advisor DENVER — Use of a multidisciplinary education initiative effectively prepared nursing and clinical staff for the challenges of managing care and follow-up of patients undergoing chimeric antigen receptor T cell (CAR-T) therapy across multiple … |
|
Evolving Education Initiative Keeps Nurses Up-to-Date on CAR T Cell Therapy Best Practices
Oncology Nurse Advisor DENVER — Use of a multidisciplinary education initiative effectively prepared nursing and clinical staff for the challenges of managing care and follow-up of patients undergoing chimeric antigen receptor T cell (CAR-T) therapy across multiple … |
Shanghai Daily (subscription) |
Positive results from gene therapy for blood cancer
Shanghai Daily (subscription) DOCTORS are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that’s on the rise. Although it’s early and the study is small — 35 people — every patient responded and all but two were in some level … |
Mesothelioma & Asbestos Awareness Center |
Hopes High for Mesothelioma Immunotherapy Treatment
Mesothelioma.net Blog (blog) But a phase II clinical trial being conducted in France has indicated that the use of immunotherapy has shown a dramatic slowdown in the speed with which mesothelioma grows after it has made its return. Researchers have found that at 12 weeks post … Things to Keep in Mind Before Joining a Clinical TrialMesothelioma & Asbestos Awareness Center (blog) |
|
AveXis and REGENXBIO Sign Licensing Agreement to Develop Therapies for ALS and Rett syndrome
ALS News Today AveXis will use REGENXBIO’s gene-delivery platform, NAV AAV9 vector, to help it develop therapies for rare, inherited and life-threatening neurological diseases. NAV AAV9 vector delivers a healthy gene, placed inside the shell of an adeno-associated … |